Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 16;60(34):18777-18782.
doi: 10.1002/anie.202106056. Epub 2021 Jul 13.

Selective 13 C-Labels on Repeating Glycan Oligomers to Reveal Protein Binding Epitopes through NMR: Polylactosamine Binding to Galectins

Affiliations

Selective 13 C-Labels on Repeating Glycan Oligomers to Reveal Protein Binding Epitopes through NMR: Polylactosamine Binding to Galectins

María J Moure et al. Angew Chem Int Ed Engl. .

Abstract

A combined chemo-enzymatic synthesis/NMR-based methodology is presented to identify, in unambiguous manner, the distinctive binding epitope within repeating sugar oligomers when binding to protein receptors. The concept is based on the incorporation of 13 C-labels at specific monosaccharide units, selected within a repeating glycan oligomeric structure. No new chemical tags are added, and thus the chemical entity remains the same, while the presence of the 13 C-labeled monosaccharide breaks the NMR chemical shift degeneracy that occurs in the non-labeled compound and allows the unique identification of the different components of the oligomer. The approach is demonstrated by a proof-of-concept study dealing with the interaction of a polylactosamine hexasaccharide with five different galectins that display distinct preferences for these entities.

Keywords: NMR; galectins; molecular recognition; polylactosamine; selective 13C-labels.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Left. The typical N‐glycan structure containing one poly‐LacNAc chain at the α6 branch. Right. The tri‐LacNAc oligomers containing selective 13C‐C6‐galactose labeling, synthesized and employed in this study.
Figure 1
Figure 1
Synthesis of tri‐LacNAc compounds 5 a, 5 b and 5 c with different 13C‐labeling schemes. Reagents and conditions: a) HP‐39, UDP‐GlcNAc; b) LgtB, UDP‐UL‐13C6‐galactose; c) LgtB, UDP‐galactose.
Figure 2
Figure 2
(A) 2D STD‐1H,13C‐HSQC NMR spectra of tri‐LacNAc 5a (with 13C6‐labeled‐galactose at residues A, B and C) in the presence of Gal‐1, Gal‐3 CRD, Gal‐7, Gal‐8 FL, and Gal‐9N (ligand:galectin molar ratios are 30:1). Left, 2D 1H,13C‐HSQC spectrum with signal assignment and right, 2D STD‐1H,13C‐HSQC NMR spectra. (B) Corresponding sum of STD effects (in percent) for all signals of the terminal galactose A (blue) and the two spectrally indistinguishable residues B and C (gray). The STD sum was computed from the net signal integrals in the 2D 1H,13C‐HSQC spectrum with on‐resonant protein saturation (2 s at 0.84 ppm using a train of 33 ms PC9_4 90° pulses) vs. off‐resonant irradiation (at −25 ppm), * with exclusion of the indistinguishable C1‐H1 and C6‐H6 signals, and C5‐H5 in Gal‐8 FL. See the Supplementary Material for further details.
Figure 3
Figure 3
Analysis of 2D STD‐1H,13C‐HSQC NMR experiments for 5b and 5c with the different galectins. The plots represent the STD intensity in % ((cross‐peak integral in the STD spectrum/cross‐peak intensity in the reference spectrum) ×100) of every CH cross‐peak of the galactose residue (represented in the X axis). Pertaining 2D STD‐1H,13C‐HSQC NMR spectra were recorded as detailed in Figure 2.

Similar articles

Cited by

References

    1. None
    1. Zhang Y., Gómez-Redondo M., Jiménez-Osés G., Ardá A., Overkleeft H. S., Marel G. A., Jiménez-Barbero J., Codée J. D. C., Angew. Chem. Int. Ed. 2020, 59, 12746–12750; - PubMed
    2. Angew. Chem. 2020, 132, 12846–12850;
    1. Gómez-Redondo M., Ardá A., Gimeno A., Jiménez-Barbero J., Drug Discovery Today Technol. 2020, 35–36, 1–11; - PubMed
    1. Zhang Q., Gimeno A., Santana D., Wang Z., Valdés-Balbin Y., Rodríguez-Noda L. M., Hansen T., Kong L., Shen M., Overkleeft H. S., Vérez-Bencomo V., van der Marel G. A., Jiménez-Barbero J., Chiodo F., Codée J. D. C., ACS Cent. Sci. 2019, 5, 1407–1416. - PMC - PubMed
    1. Nagae M., Yamaguchi Y., Int. J. Mol. Sci. 2014, 15, 3768–3783. - PMC - PubMed

Publication types

LinkOut - more resources